Lack of long-lasting hydrosalpinx in A/J mice correlates with rapid but transient chlamydial ascension and neutrophil recruitment in the oviduct following intravaginal inoculation with Chlamydia muridarum

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 2688-2696

  Zhang, Hongbo ^a,c   Zhou, Zhou ^a   Chen, Jianlin ^a,c   Wu, Ganqiu ^a,c   Yang, Zhangsheng ^a   Zhou, Zhiguang ^c   Baseman, Joel ^a   Zhang, Jin ^b   Reddick, Robert Lee ^a   Zhong, Guangming ^a  

^a University of Texas Health Science Center   (United States)

^b Methodist Hospital   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HYDROSALPINX; IMMUNE RESPONSE; INFLAMMATION; INOCULATION; MOUSE; NEUTROPHIL; NONHUMAN; OVIDUCT; PRIORITY JOURNAL;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FALLOPIAN TUBE DISEASES; FALLOPIAN TUBES; FEMALE; INFLAMMATION; MICE; MICE, INBRED STRAINS; REPRODUCTIVE TRACT INFECTIONS;

EID: 84903134003     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00055-14     Document Type: Article

References (41)

1. Sherman KJ, Daling JR, Stergachis A, Weiss NS, Foy HM, Wang SP, Grayston JT. 1990. Sexually transmitted diseases and tubal pregnancy. Sex. Transm. Dis. 17:115-121. http://dx.doi.org/10.1097/00007435-199007000-00001.
2. de la Maza LM, Pal S, Khamesipour A, Peterson EM. 1994. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect. Immun. 62:2094-2097.
3. Shah AA, Schripsema JH, Imtiaz MT, Sigar IM, Kasimos J, Matos PG, Inouye S, Ramsey KH. 2005. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex. Transm. Dis. 32:49-56. http://dx.doi.org/10.1097/01.olq.0000148299.14513.11.
4. Murthy AK, Li W, Guentzel MN, Zhong G, Arulanandam BP. 2011. Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge. Vaccine 29:2519-2522. http://dx.doi.org/10.1016/j.vaccine.2011.01.074.
5. Stephens RS. 2003. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11:44-51. http://dx.doi.org/10.1016/S0966-842X(02)00011-2.
6. Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, Zhong G. 2008. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect. Immun. 76:515-522. http://dx.doi.org/10.1128/IAI.01064-07.
7. Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, Caldwell HD. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4704-4714.
8. Pal S, Peterson EM, de la Maza LM. 2005. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect. Immun. 73:8153-8160. http://dx.doi.org/10.1128/IAI.73.12.8153-8160.2005.
9. Rodgers AK, Budrys NM, Gong S, Wang J, Holden A, Schenken RS, Zhong G. 2011. Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil. Steril. 96:715-721. http://dx.doi.org/10.1016/j.fertnstert.2011.06.021.
10. Chanelles O, Ducarme G, Sifer C, Hugues JN, Touboul C, Poncelet C. 2011. Hydrosalpinx and infertility: what about conservative surgical management? Eur. J. Obstet. Gynecol. Reprod. Biol. 159:122-126. http://dx.doi.org/10.1016/j.ejogrb.2011.07.004.
11. Budrys NM, Gong S, Rodgers AK, Wang J, Louden C, Shain R, Schenken RS, Zhong G. 2012. Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet. Gynecol. 119:1009-1016. http://dx.doi.org/10.1097/AOG.0b013e3182519326.
12. Lei L, Chen J, Hou S, Ding Y, Yang Z, Zeng H, Baseman J, Zhong G. 2014. Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum. Infect. Immun. 82: 983-992. http://dx.doi.org/10.1128/IAI.01543-13.
13. Darville T, O'Neill JM, Andrews CW, Jr, Nagarajan UM, Stahl L, Ojcius DM. 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 171:6187-6197.
14. Chen L, Lei L, Chang X, Li Z, Lu C, Zhang X, Wu Y, Yeh IT, Zhong G. 2010. Mice deficient in MyD88 develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J. Immunol. 184:2602-2610. http://dx.doi.org/10.4049/jimmunol.0901593.
15. Barteneva N, Theodor I, Peterson EM, de la Maza LM. 1996. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect. Immun. 64:4830-4833.
16. Andrew DW, Cochrane M, Schripsema JH, Ramsey KH, Dando SJ, O'Meara CP, Timms P, Beagley KW. 2013. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS One 8:e76664. http://dx.doi.org/10.1371/journal.pone.0076664.
17. Darville T, Andrews CW, Jr, Sikes JD, Fraley PL, Rank RG. 2001. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect. Immun. 69:3556-3561. http://dx.doi.org/10.1128/IAI.69.6.3556-3561.2001.
18. Imtiaz MT, Schripsema JH, Sigar IM, Kasimos JN, Ramsey KH. 2006. Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection. Infect. Immun. 74:5513-5521. http://dx.doi.org/10.1128/IAI.00730-06.
19. Ramsey KH, Sigar IM, Rana SV, Gupta J, Holland SM, Byrne GI. 2001. Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect. Immun. 69:7374-7379. http://dx.doi.org/10.1128/IAI.69.12.7374-7379.2001.
20. Nagarajan UM, Sikes JD, Yeruva L, Prantner D. 2012. Significant role of IL-1 signaling, but limited role of inflammasome activation, in oviduct pathology during Chlamydia muridarum genital infection. J. Immunol. 188:2866-2875. http://dx.doi.org/10.4049/jimmunol.1103461.
21. Igietseme JU, Omosun Y, Partin J, Goldstein J, He Q, Joseph K, Ellerson D, Ansari U, Eko FO, Bandea C, Zhong G, Black CM. 2013. Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J. Infect. Dis. 207:1095-1104. http://dx.doi.org/10.1093/infdis/jit009.
22. Chen L, Cheng W, Shivshankar P, Lei L, Zhang X, Wu Y, Yeh IT, Zhong G. 2009. Distinct roles of CD28-and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice. Infect. Immun. 77: 3080-3089. http://dx.doi.org/10.1128/IAI.00611-08.
23. Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP. 2011. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 79:2928-2935. http://dx.doi.org/10.1128/IAI.05022-11.
24. Cheng W, Shivshankar P, Zhong Y, Chen D, Li Z, Zhong G. 2008. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect. Immun. 76:942-951. http://dx.doi.org/10.1128/IAI.01313-07.
25. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Investig. 99:77-87. http://dx.doi.org/10.1172/JCI119136.
26. Chen C, Chen D, Sharma J, Cheng W, Zhong Y, Liu K, Jensen J, Shain R, Arulanandam B, Zhong G. 2006. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect. Immun. 74:4826-4840. http://dx.doi.org/10.1128/IAI.00081-06.
27. Li Z, Lu C, Peng B, Zeng H, Zhou Z, Wu Y, Zhong G. 2012. Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase. PLoS One 7:e32997. http://dx.doi.org/10.1371/journal.pone.0032997.
28. Zhong G, Reis e Sousa C, Germain RN. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. U. S. A. 94:13856-13861. http://dx.doi.org/10.1073/pnas.94.25.13856.
29. Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM, Greenberg AH, Zhong G. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187:487-496. http://dx.doi.org/10.1084/jem.187.4.487.
30. Zhong G, Fan P, Ji H, Dong F, Huang Y. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942. http://dx.doi.org/10.1084/jem.193.8.935.
31. O'Connell CM, Ingalls RR, Andrews CW, Jr, Scurlock AM, Darville T. 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 179:4027-4034.
32. Pellicoro A, Ramachandran P, Iredale JP. 2012. Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 5(Suppl 1):S26.
33. Broeze KA, Opmeer BC, Van Geloven N, Coppus SF, Collins JA, Den Hartog JE, Van der Linden PJ, Marianowski P, Ng EH, Van der Steeg JW, Steures P, Strandell A, Van der Veen F, Mol BW. 2011. Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis. Hum. Reprod. Update 17:293-300. http://dx.doi.org/10.1093/humupd/dmq056.
34. Chen L, Lei L, Zhou Z, He J, Xu S, Lu C, Chen J, Yang Z, Wu G, Yeh IT, Zhong G, Wu Y. 2013. Contribution of interleukin-12 p35 (IL-12p35) and IL-12p40 to protective immunity and pathology in mice infected with Chlamydia muridarum. Infect. Immun. 81:2962-2971. http://dx.doi.org/10.1128/IAI.00161-13.
35. Lu C, Zeng H, Li Z, Lei L, Yeh IT, Wu Y, Zhong G. 2012. Protective immunity against mouse upper genital tract pathology correlates with high IFNgamma but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway. Vaccine 30:475-485. http://dx.doi.org/10.1016/j.vaccine.2011.10.059.
36. Tuite A, Elias M, Picard S, Mullick A, Gros P. 2005. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun. 6:672-682. http://dx.doi.org/10.1038/sj.gene.6364254.
37. Mashruwala MA, Smith AK, Lindsey DR, Moczygemba M, Wetsel RA, Klein JR, Actor JK, Jagannath C. 2011. A defect in the synthesis of interferon-gamma by the T cells of complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. Tuberculosis 91(Suppl 1):S82-S89. http://dx.doi.org/10.1016/j.tube.2011.10.016.
38. Copland DA, Hussain K, Baalasubramanian S, Hughes TR, Morgan BP, Xu H, Dick AD, Nicholson LB. 2010. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin. Exp. Immunol. 159:303-314. http://dx.doi.org/10.1111/j.1365-2249.2009.04070.x.
39. Durigutto P, Macor P, Ziller F, De Maso L, Fischetti F, Marzari R, Sblattero D, Tedesco F. 2013. Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. PLoS One 8:e58696. http://dx.doi.org/10.1371/journal.pone.0058696.
40. Bode J, Dutow P, Sommer K, Janik K, Glage S, Tummler B, Munder A, Laudeley R, Sachse KW, Klos A. 2012. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci. PLoS One 7:e50327. http://dx.doi.org/10.1371/journal.pone.0050327.
41. Ramos TN, Darley MM, Weckbach S, Stahel PF, Tomlinson S, Barnum SR. 2012. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. J. Biol. Chem. 287:24734-24738. http://dx.doi.org/10.1074/jbc.C112.378364.